ScienceDex / Researcher record
Kai W Wucherpfennig
- Massachusetts General Hospital · Dermatology (investigator's affiliation)
- Brigham and Women's Hospital · Neurosurgery (investigator's affiliation)
- Dana-Farber Cancer Institute (no department on record)
From the FY2024 NIH awards this investigator leads as contact PI. The department is the award's.
FY2024 NIH rank #6,788
- Program Leader
- R01 Holder
- Multi-Institutional
- Early Career
- Diverse Portfolio
NIH Funding · FY2024
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
Linked awards ($M)Award-linked rank
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2024 | $1,748,455 | 4 | #6,788 |
| 2025 | $2,199,190 | 3 | #5,744 |
| 2026 | $18,815,163 | 4 | #203 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY2024 · selected4 records
- FY20253 records
- FY20264 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 1882347Search this ID in NIH RePORTER
- ORCID iD
- https://orcid.org/0000-0002-1829-302XVerified identifier for this researcher
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.
FY2024 award records by amount
NIH award records listing Kai W Wucherpfennig as a PI. Multi-PI records show the full award amount for context.
- 2P01CA163222-11P01Contact PITargetable epigenetic and transcriptional mechanisms in melanoma thatshape the microenvironmentMassachusetts General Hospital · Dermatology (investigator's affiliation)$537.6Kaward amount
- $509.8Kaward amount
- 5R01CA251599-05R01Contact PITargeting of a Major Immune Evasion Pathway in Triple-negative Breast Cancer$461.1Kaward amount
- 5P01CA236749-05P01Contact PIUnderstanding and Overcoming T cell Immunosuppression in GlioblastomaBrigham and Women's Hospital · Neurosurgery (investigator's affiliation)$239.9Kaward amount
Award organizations
Organizations that administered FY2024 awards listing Kai W Wucherpfennig as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardDana-Farber Cancer Institute
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #6788
- 2025$2M Cumulative Funding
- 2025Multi-Institutional ResearchAwards at 3 institutions
- 2025R01 Grant Holder
- 2025Program/Center Grant Leader
- 2026$5M Cumulative Funding
- 2026$10M Cumulative Funding
- 2026Entered Top 25% NationallyRanked #203
- 2026Entered Top 10% NationallyRanked #203
- 2026Entered Top 5% NationallyRanked #203
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Kai W Wucherpfennig.
A. Heather Eliassen
Dana-Farber Cancer Institute
3
shared awards
Andrew A Lane
Dana-Farber Cancer Institute
3
shared awards
Benjamin Levine Ebert
Dana-Farber Cancer Institute
3
shared awards
Brian Matthew Wolpin
Dana-Farber Cancer Institute
3
shared awards
David E Fisher
Massachusetts General Hospital
3
shared awards
Deborah J Goff
Dana-Farber Cancer Institute
3
shared awards
Eliezer M Van Allen
Dana-Farber Cancer Institute
3
shared awards
Frank S Hodi
Dana-Farber Cancer Institute
3
shared awards
Franziska Michor
Dana-Farber Cancer Institute
3
shared awards
Geoffrey I. Shapiro
Dana-Farber Cancer Institute
3
shared awards